Afluria Market Trend Analysis Research Report by Formulation (Pre-Filled Syringes, Multi-Dose Vials), By Clinical Indication (Influenza Prevention), by Distribution Channel, by End User, and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Global Forecast to 2034.
Feb-2025 Formats | PDF | Category: Pharma and Healthcare | Delivery: 24 to 72 Hours
“The Afluria industry is expected to expand from $XX million in 2025 to $ XX million in 2034, with a compound annual growth rate of XX%. “
Afluria Market: Overview and Growth in the Upcoming Year
The Afluria market is expanding due to the increasing demand for influenza vaccines, particularly Seqirus’s trivalent vaccine, Afluria. The COVID-19 pandemic has heightened awareness of the importance of immunizations in preventing infectious diseases. Afluria, a market leader, is known for its efficacy and safety, making it a crucial product in the market. The increasing demand for influenza vaccines is driving the market growth.
The Afluria market faces challenges, including vaccine hesitancy due to concerns about safety and efficacy. To overcome this, education and communication methods are needed to increase trust in vaccination’s benefits. The market offers opportunities for expansion through new formulations and technologies, which can improve vaccine efficacy and convenience. Additionally, increasing market access in underserved areas can boost immunization rates and public health results.
For Insights Consultancy’s latest market intelligence study, “Global Afluria Market 2025, Growth Opportunities, and Forecast,” provides a comprehensive analysis of the Pharma and healthcare industry. The report includes demand analysis, industry insights, competition intelligence, and a customer database. It also offers strategic insights into future trends, growth determinants, supplier landscape, demand landscape, CAGR, and pricing analysis. The study also includes Porter’s Five Forces Analysis, PESTLE Analysis, Value Chain Analysis, 4 Ps’ Analysis, Market Attractiveness Analysis, BPS Analysis, and Ecosystem Analysis.
Do you think, if this report could be of your interest? If yes, request Sample Copy of this Report: https://forinsightsconsultancy.com/reports/request-sample-afluria-market
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 110+ is available for purchase to all the interested stakeholders.
Top Companies Covered In This Report:
- CSL Seqirus
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2034, Y-o-Y growth rate, and CAGR):
Segment by Formulation
- Pre-Filled Syringes
- Multi-Dose Vials
Segment byClinical Indications
- Influenza Prevention
Segment byDistribution Channel
- Hospitals And Clinics
- Retail Pharmacies
- Government Supplier
Segment by End Users
- Pediatric
- Adult
- Geriatric
Regional Deep-dive Analysis:
The report provides in-depth qualitative and quantitative data on the Afluria Market for all of the regions and countries listed below:
- North America includes the United States, Canada, and Mexico.
- Europe includes Germany, France, Italy, the United Kingdom, Scandinavia, Benelux, Russia, and the rest of Europe.
- Asia-Pacific includes Japan, South Korea, India, China, Southeast Asia, and Australia.
- South America (including Brazil, Argentina, and the rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa)
Each country is studied in detail, and the study includes qualitative and quantitative analysis of the Afluria Market in that country.
North America
The Afluria market in North America is expanding due to increased awareness of immunization, with the US leading the market with high flu vaccination adoption rates, supported by prominent market participants and government vaccination promotion measures.
Europe
Europe is a crucial market for Afluria due to high demand for flu vaccines in countries like the UK, Germany, and France, rising winter influenza cases, rising healthcare costs, and good reimbursement regulations, promoting market expansion.
Asia Pacific
The Asia Pacific region is experiencing a surge in demand for Afluria due to increased awareness of preventative healthcare practices, driven by countries like China, Japan, and India, and the expansion of healthcare infrastructure and government efforts to combat influenza.
Middle East
The Middle East’s Afluria market is expanding due to government efforts to improve immunization programs, with countries like Saudi Arabia and the UAE investing in vaccination initiatives to reduce influenza prevalence, thereby driving market expansion.
Recent News:
In July 2022, Seqirus, a UK-based influenza vaccine producer, partnered with the Biomedical Advanced Research and Development Authority (BARDA) and the University of Liverpool Pandemic Institute. These collaborations aimed to enhance vaccine distribution and improve public health outcomes. BARDA is a US government agency, that focuses on developing medical countermeasures for public health emergencies, while the University of Liverpool Pandemic Institute is a UK-based institute, that seeks to improve worldwide pandemic responses through research, preparedness, and policy development.
The research provides answers to the following key questions:
- What is the expected growth rate of the Afluria market from 2025-2034?
- What are the key driving forces shaping the market during the forecast period?
- Who are the major market vendors and what winning strategies have helped them occupy a strong foothold in the Afluria market?
- What are the prominent market trends influencing the market’s development?
Buy the Complete Report with an Impressive Discount (Up to 30% Off) @: https://forinsightsconsultancy.com/buy-now-afluria-market
Key insights provided by the report that could help you take critical strategic decisions?
- Regional reports analyse product/service consumption and market factors in each region.
- Reports highlight possibilities and dangers for suppliers in the Afluria business globally.
- The report identifies regions and sectors with the highest growth potential.
- It provides a competitive market ranking of major companies, as well as information on new product launches, partnerships, business expansions, and acquisitions.
- The report includes a comprehensive corporate profile with company overviews, insights, product benchmarks, and SWOT analysis for key market participants.
Customization: We can provide following things 1) On request more company profiles (competitors) 2) Data about particular country or region 3) We will incorporate the same with no additional cost (Post conducting feasibility).
Any Requirement Contact us: https://forinsightsconsultancy.com/contact-us/
Table of Contents
- Executive Summary
- Afluria Industry Characteristics
- Afluria Industry Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
- Afluria Industry Trends And Strategies
- Afluria Industry – Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- Global Afluria Growth Analysis And Strategic Analysis Framework
6.1. Global Afluria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Afluria Industry Growth Rate Analysis
6.4. Global Afluria Historic Market Size and Growth, 2019 – 2024, Value ($ Billion)
6.5. Global Afluria Forecast Market Size and Growth, 2025 – 2034, 2034F, Value ($ Billion)
6.6. Global Afluria Total Addressable Market (TAM)
- Global Afluria Industry Pricing Analysis & Forecasts
- Afluria Industry Segmentation
8.1. Global Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Pre-Filled Syringes
Multi-Dose Vials
8.2. Global Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Influenza Prevention
8.3. Global Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Hospitals And Clinics
Retail Pharmacies
Government Supplier
8.4. Global Afluria Industry, Segmentation By End Users, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
Pediatric
Adult
Geriatric
- Global Afluria Industry Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
- Afluria Industry Regional And Country Analysis
10.1. Global Afluria Industry, Split By Region, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
10.2. Global Afluria Industry, Split By Country, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Asia-Pacific Afluria Industry
11.1. Asia-Pacific Afluria Industry Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
11.3. Asia-Pacific Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
11.4. Asia-Pacific Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- China Afluria Industry
12.1. China Afluria Industry Overview
12.2. China Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F,$ Billion
12.3. China Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F,$ Billion
12.4. China Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F,$ Billion
- India Afluria Industry
13.1. India Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
13.2. India Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
13.3. India Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Japan Afluria Industry
14.1. Japan Afluria Industry Overview
14.2. Japan Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
14.3. Japan Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
14.4. Japan Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Australia Afluria Industry
15.1. Australia Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
15.2. Australia Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
15.3. Australia Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- South Korea Afluria Industry
16.1. South Korea Afluria Industry Overview
16.2. South Korea Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
16.3. South Korea Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
16.4. South Korea Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Western Europe Afluria Industry
17.1. Western Europe Afluria Industry Overview
17.2. Western Europe Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
17.3. Western Europe Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
17.4. Western Europe Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- UK Afluria Industry
18.1. UK Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
18.2. UK Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
18.3. UK Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Germany Afluria Industry
19.1. Germany Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
19.2. Germany Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
19.3. Germany Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- France Afluria Industry
20.1. France Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
20.2. France Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
20.3. France Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Eastern Europe Afluria Industry
21.1. Eastern Europe Afluria Industry Overview
21.2. Eastern Europe Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
21.3. Eastern Europe Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
21.4. Eastern Europe Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- North America Afluria Industry
22.1. North America Afluria Industry Overview
22.2. North America Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
22.3. North America Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
22.4. North America Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- USA Afluria Industry
23.1. USA Afluria Industry Overview
23.2. USA Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
23.3. USA Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
23.4. USA Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Canada Afluria Industry
24.1. Canada Afluria Industry Overview
24.2. Canada Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
24.3. Canada Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
24.4. Canada Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- South America Afluria Industry
25.1. South America Afluria Industry Overview
25.2. South America Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
25.3. South America Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
25.4. South America Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Middle East Afluria Industry
26.1. Middle East Afluria Industry Overview
26.2. Middle East Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
26.3. Middle East Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
26.4. Middle East Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Africa Afluria Industry
27.1. Africa Afluria Industry Overview
27.2. Africa Afluria Industry, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
27.3. Africa Afluria Industry, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
27.4. Africa Afluria Industry, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2025-2034F, 2034F, $ Billion
- Afluria Industry Competitive Landscape And Company Profiles
28.1. Afluria Industry Competitive Landscape
28.2. Afluria Industry Company Profiles
28.2.1. CSL Seqirus Overview, Products and Services, Strategy and Financial Analysis
- Global Afluria Industry Pipeline Analysis
29.1. High Level Clinic Trail Information
- Global Afluria Industry Competitive Benchmarking And Dashboard
- Key Mergers And Acquisitions In The Afluria Industry
- Recent Developments In The Afluria Industry
- Afluria Industry High Potential Countries, Segments and Strategies
33.1 Afluria Industry In 2034 – Countries Offering Most New Opportunities
33.2 Afluria Industry In 2034 – Segments Offering Most New Opportunities
33.3 Afluria Industry In 2034 – Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
- Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. For Insights Consultancy
34.6. Copyright And Disclaimer
Select PDF License
Single User: $3499
Multiple Users: $4499
Corporate Users: $5499
